Ischemic stroke represents the leading cause of adult neurological disability, with no effective therapeutic strategy. Stem cell transplantation promises a new promising for treating stroke, through cell replacement and cytokine paracrine. However, due to the effect of hostile immune microenvironment, the survival and differentiation of stem cells are limited in vivo. Furthermore, the delayed inflammatory response to stroke induced secondary neurological injury. IFN-γ as pro-inflammatory cytokine has the potential to protect stem cell population during inflammatory response, as well as stimulates neurogenesis of stem cells. The purpose of this study was to investigate whether co-injection of neural stem cells and IFN-γ can improve therapeutic outcomes in ischemic stroke model. In this study, we found that IFN-γ did not interfere with the proliferation of neural stem cells (NSCs) in vitro and induced levels of subsequent neuronal differentiation significantly superior to those of other four cytokines BDNF, VEGF, TGF-β, and IGF-1. Co-delivery of IFN-γ (concentration: 50 ng) enhanced the effectiveness of NSC transplantation therapy in ischemic rats. And combined IFN-γ treatment significantly increased neurogenesis in vivo, with more BrdU/DCX dual-positive cells found in ischemic areas. Moreover, co-treatment with IFN-γ and NSCs exerted additional neurological benefits compared with NSC transplantation alone. In conclusion, low concentration of IFN-γ can promote the functions of transplanted NSCs and facilitate their ability of neurological repair. Thus, our findings suggest that co-delivery of NSCs and IFN-γ without genetic modification may be an effective, simple, and novel approach for the treatment of ischemic stroke.
Get full access to this article
View all access options for this article.
References
1.
FeiginVL, ForouzanfarMH, KrishnamurthiR, MensahGA, ConnorM, BennettDA, MoranAE, SaccoRL, AndersonL, et al. (2014). Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet, 383:245–254.
2.
LanghorneP, BernhardtJ and KwakkelG. (2011). Stroke rehabilitation. Lancet, 377:1693–1702.
3.
FisherM. (2011). New approaches to neuroprotective drug development. Stroke, 42:S24–S27.
KwakkelG, van PeppenR, WagenaarRC, Wood DauphineeS, RichardsC, AshburnA, MillerK, LincolnN, PartridgeC, WellwoodI and LanghorneP. (2004). Effects of augmented exercise therapy time after stroke: a meta-analysis. Stroke, 35:2529–2539.
6.
KalladkaD and MuirKW. (2014). Brain repair: cell therapy in stroke. Stem Cells Cloning, 7:31–44.
7.
ChenL, ZhangG, GuY and GuoX. (2016). Meta-Analysis and Systematic Review of Neural Stem Cells therapy for experimental ischemia stroke in preclinical studies. Sci Rep, 6:32291.
8.
BanerjeeS, WilliamsonD, HabibN, GordonM and ChatawayJ. (2011). Human stem cell therapy in ischaemic stroke: a review. Age Ageing, 40:7–13.
9.
ChenLK, ZhangGL, KhanAA, GuoXY and GuYC. (2016). Clinical efficacy and meta-analysis of stem cell therapies for patients with brain ischemia. Stem Cells Int, 2016:6129579.
10.
KalladkaD, SindenJ, PollockK, HaigC, McLeanJ, SmithW, McConnachieA, SantoshC, BathPM, DunnL and MuirKW. (2016). Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. Lancet, 388:787–796.
11.
GiffardRG, HanRQ, EmeryJF, DuanM and PittetJF. (2008). Regulation of apoptotic and inflammatory cell signaling in cerebral ischemia: the complex roles of heat shock protein 70. Anesthesiology, 109:339–348.
12.
DoeppnerTR, El AanbouriM, DietzGP, WeiseJ, SchwartingS and BahrM. (2010). Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke. Neurobiol Dis, 40:265–276.
13.
NakagomiN, NakagomiT, KuboS, Nakano-DoiA, SainoO, TakataM, YoshikawaH, SternDM, MatsuyamaT and TaguchiA. (2009). Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction. Stem Cells, 27:2185–2195.
14.
LiJ, TangYH, WangYT, TangRB, JiangWF, YangGY and GaoWQ. (2014). Neurovascular recovery via cotransplanted neural and vascular progenitors leads to improved functional restoration after ischemic stroke in rats. Stem Cell Reports, 3:101–114.
15.
YilmazG, ArumugamTV, StokesKY and GrangerDN. (2006). Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation, 113:2105–2112.
16.
LiH, KoenigAM, SloanP and LeipzigND. (2014). In vivo assessment of guided neural stem cell differentiation in growth factor immobilized chitosan-based hydrogel scaffolds. Biomaterials, 35:9049–9057.
17.
FantettiKN, GrayEL, GanesanP, KulkarniA and O'DonnellLA. (2016). Interferon gamma protects neonatal neural stem/progenitor cells during measles virus infection of the brain. J Neuroinflammation, 13:107.
18.
WongG, GoldshmitY and TurnleyAM. (2004). Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol, 187:171–177.
19.
CossettiC, IraciN, MercerTR, LeonardiT, AlpiE, DragoD, Alfaro-CervelloC, SainiHK, DavisMP, et al. (2014). Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell, 56:193–204.
20.
AndresRH, HorieN, SlikkerW, Keren-GillH, ZhanK, SunGH, ManleyNC, PereiraMP, SheikhLA, et al. (2011). Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain, 134:1777–1789.
21.
JinR, YangG and LiG. (2010). Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol, 87:779–789.
22.
WeinsteinJR, KoernerIP and MollerT. (2010). Microglia in ischemic brain injury. Future Neurol, 5:227–246.
23.
LiuFF, XuanAG, ChenY, ZhangJD, XuLP, YanQJ and LongDH. (2014). Combined effect of nerve growth factor and brain-derived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol Med Rep, 10:1739–1745.
24.
WangL and KisaalitaWS. (2011). Administration of BDNF/ginsenosides combination enhanced synaptic development in human neural stem cells. J Neurosci Methods, 194:274–282.
25.
LeeWD, WangKC, TsaiYF, ChouPC, TsaiLK and ChienCL. (2016). Subarachnoid hemorrhage promotes proliferation, differentiation, and migration of neural stem cells via BDNF upregulation. PLoS One, 11:e0165460.
26.
WuCC, LienCC, HouWH, ChiangPM and TsaiKJ. (2016). Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease. Sci Rep, 6:27358.
27.
XuH and HeilshornSC. (2013). Microfluidic investigation of BDNF-enhanced neural stem cell chemotaxis in CXCL12 gradients. Small, 9:585–595.
28.
RosenblumS, SmithTN, WangN, ChuaJY, WestbroekE, WangK and GuzmanR. (2015). BDNF pretreatment of human embryonic-derived neural stem cells improves cell survival and functional recovery after transplantation in hypoxic-ischemic stroke. Cell Transplant, 24:2449–2461.
29.
LichtT, RotheG, KreiselT, WolfB, BennyO, RooneyAG, Ffrench-ConstantC, EnikolopovG and KeshetE. (2016). VEGF preconditioning leads to stem cell remodeling and attenuates age-related decay of adult hippocampal neurogenesis. Proc Natl Acad Sci U S A, 113:E7828–E7836.
30.
HanJ, CalvoCF, KangTH, BakerKL, ParkJH, ParrasC, LevittasM, BirbaU, Pibouin-FragnerL, et al. (2015). Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans. Cell Rep, 10:1158–1172.
31.
ChuK, ParkKI, LeeST, JungKH, KoSY, KangL, SinnDI, LeeYS, KimSU, KimM and RohJK. (2005). Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci Res, 53:384–390.
32.
ZhangXH, ZhangL, ChengX, GuoYX, SunXH, ChenG, LiHM, LiPC, LuXH, et al. (2014). IGF-1 promotes Brn-4 expression and neuronal differentiation of neural stem cells via the PI3K/Akt Pathway. PLoS One, 9:e113801.
33.
SupenoNE, PatiS, HadiRA, GhaniARI, MustafaZ, AbdullahJM, IdrisFM, HanX and JaafarH. (2013). IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF/FGF-responsive striatal neural stem cells. Int J Med Sci, 10:522–531.
34.
KandasamyM, LehnerB, KrausS, SanderPR, MarschallingerJ, RiveraFJ, TrumbachD, UeberhamU, ReitsamerHA, et al. (2014). TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med, 18:1444–1459.
LiHL, KostulasN, HuangYM, XiaoBG, van der MeideP, KostulasV, GiedraitasV and LinkH. (2001). IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J Neuroimmunol, 116:5–14.
37.
AhnJ, LeeJ and KimS. (2015). Interferon-gamma inhibits the neuronal differentiation of neural progenitor cells by inhibiting the expression of Neurogenin2 via the JAK/STAT1 pathway. Biochem Biophys Res Commun, 466:52–59.
38.
LumM, CrozeE, WagnerC, McLenachanS, MitrovicB and TurnleyAM. (2009). Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is coupled to neuronal differentiation. J Neuroimmunol, 206:32–38.
39.
ZahirT, ChenYF, MacDonaldJF, LeipzigN, TatorCH and ShoichetMS. (2009). Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells Dev, 18:1423–1432.
40.
KimSJ, SonTG, KimK, ParkHR, MattsonMP and LeeJ. (2007). Interferon-gamma promotes differentiation of neural progenitor cells via the JNK pathway. Neurochem Res, 32:1399–1406.
